Page last updated: 2024-08-21

treosulfan and Anemia, Sickle Cell

treosulfan has been researched along with Anemia, Sickle Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devadasan, D; Goldman, FD; Pawlik, KM; Sun, CW; Townes, TM; Westin, ER; Wu, LC1
Comoli, P; Giorgiani, G; Giraldi, E; Locatelli, F; Merli, P; Mina, T; Regazzi, M; Strocchio, L; Vinti, L; Zecca, M1

Other Studies

2 other study(ies) available for treosulfan and Anemia, Sickle Cell

ArticleYear
Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:8

    Topics: Anemia, Sickle Cell; Animals; Antibodies; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Busulfan; Disease Models, Animal; Graft Survival; Mice; Proto-Oncogene Proteins c-kit; Transplantation Conditioning; Treatment Outcome

2018
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
    British journal of haematology, 2015, Volume: 169, Issue:5

    Topics: Adolescent; Anemia, Sickle Cell; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2015